Location of Repository

Dual-modal tracking of transplanted mesenchymal stem cells after myocardial infarction

By Yefei Li, Yuyu Yao, Zulong Sheng, Yanxiaoxiao Yang and Genshan Ma
Topics: Original Research
Publisher: Dove Medical Press
OAI identifier: oai:pubmedcentral.nih.gov:3090278
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles



    1. (2008). A mouse model for juvenile doxorubicin-induced cardiac dysfunction. Pediatr Res.
    2. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.
    3. Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells.
    4. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling.
    5. Autologous bone marrow derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.
    6. (2009). Bone marrow-derived stem/progenitor cells: their use in clinical studies for the treatment of myocardial infarction. Heart Lung Circ.
    7. Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study.
    8. (2010). Cell delivery and tracking in postmyocardial infarction cardiac stem cell therapy: an introduction for clinical researchers. Heart Fail Rev.
    9. Cell survival and redistribution after transplantation into damaged myocardium.
    10. Cell tracking with optical imaging.
    11. CINE-MR imaging of the normal and infarcted rat heart using an
    12. Clinical hurdles for the transplantation of cardiomyocytes derived from human embryonic stem cells: role of molecular imaging.
    13. (2007). Hajjar RJ. In vivo tracking in cardiac stem cell-based therapy. Prog Cardiovasc Dis.
    14. (2008). Heart regeneration: what cells to use and how? Curr Opin Pharmacol.
    15. Human bone marrow-derived adult stem cells for post-myocardial infarction cardiac repair: current status and future directions.
    16. (2009). Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res.
    17. (2010). In vivo magnetic resonance imaging of injected endothelial progenitor cells after myocardial infarction in rats. Mol Imaging Bio.
    18. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction.
    19. Intra-myocardial delivery of mesenchymal stem cells ameliorates left ventricular and cardiomyocyte contractile dysfunction following myocardial infarction. Toxicol Lett.
    20. Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction.
    21. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.
    22. (2007). Intravenous infusion of bone marrow mesenchymal stem cells improves myocardial function in a rat model of myocardial ischemia. Crit Care Med.
    23. Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties.
    24. (2004). Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res.
    25. (2007). Mesenchymal stem cells for cardiac regenerative therapy. Handb Exp Pharmacol.
    26. Mesenchymal stem cells for the treatment of heart disease.
    27. (2005). Mesenchymal stem cells in the infarcted heart. Coron Artery Dis.
    28. (2007). Noninvasive tracking of cardiac embryonic stem cells in vivo using magnetic resonance imaging techniques. Stem Cells.
    29. (2007). Stem cell mechanisms and paracrine effects: potential in cardiac surgery.
    30. (2009). Stem cell therapy for ischemic heart disease: where are we? Curr Opin Organ Transplan.
    31. (2003). Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation.
    32. (2003). Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution. Circulation.
    33. (2006). vertical bore MR system. J Cardiovasc Magn Reson.
    34. (2010). Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ Res.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.